HCV infection induces mitochondrial bioenergetic unbalance: Causes and effects

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1787, Issue 5, 2009, Pages 539-546

  Piccoli, C ^a   Quarato, G ^a   Ripoli, M ^a   D'Aprile, A ^a   Scrima, R ^a   Cela, O ^a   Boffoli, D ^a   Moradpour, D ^b   Capitanio, N ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Ca2+ homeostasis; Hepatitis C virus; Mitochondria; Redox signaling

Indexed keywords

CALCIUM ION; DANTROLENE; HYPOXIA INDUCIBLE FACTOR; NITROGEN; REACTIVE OXYGEN METABOLITE; RUTHENIUM RED;

CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM; GLYCOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MITOCHONDRIAL TOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

CALCIUM; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HOMEOSTASIS; HUMANS; MITOCHONDRIA; NADH DEHYDROGENASE; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION;

HEPATITIS C VIRUS;

EID: 67349286520     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2008.11.008     Document Type: Review

References (71)

1. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5 (2005) 558-567
2. Moradpour D., Penin F., and Rice C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5 (2007) 453-463
3. Tardif K.D., Waris G., and Siddiqui A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 13 (2005) 159-163
4. Korenaga M., Okuda M., Otani K., Wang T., Li Y., and Weinman S.A. Mitochondrial dysfunction in hepatitis C. J. Clin. Gastroenterol. 39 4 Suppl 2 (2005) S162-166
5. Piccoli C., Scrima R., Quarato G., D'Aprile A., Ripoli M., Lecce L., Boffoli D., Moradpour D., and Capitanio N. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 46 (2007) 58-65
6. Wang T., and Weinman S.A. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J. Gastroenterol. Hepatol. 21 Suppl 3 (2006) S34-37
7. Piccoli C., Scrima R., D'Aprile A., Ripoli M., Lecce L., Boffoli D., and Capitanio N. Mitochondrial dysfunction in hepatitis C virus infection. Biochim. Biophys. Acta 1757 (2006) 1429-1437
8. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
9. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 283 (1999) 1488-1493
10. Chalah A., and Khosravi-Far R. The mitochondrial death pathway. Adv. Exp. Med. Biol. 61 (2008) 25-45
11. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
12. Barbaro G., Di Lorenzo G., Asti A., Ribersani M., Belloni G., Grisorio B., Filice G., and Barbarini G. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am. J. Gastroenterol. 94 (1999) 2198-2205
13. Mottola G., Cardinali G., Ceccacci A., Trozzi C., Bartholomew L., Torrisi M.R., Pedrazzini E., Bonatti S., and Migliaccio G. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 293 (2002) 31-43
14. Schwer B., Ren S., Pietschmann T., Kartenbeck J., Kaehlcke K., Bartenschlager R., Yen T.S., and Ott M. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J. Virol. 78 (2004) 7958-7968
15. Suzuki R., Sakamoto S., Tsutsumi T., Rikimaru A., Tanaka K., Shimoike T., Moriishi K., Iwasaki T., Mizumoto K., Matsuura Y., Miyamura T., and Suzuki T. Molecular determinants for subcellular localization of hepatitis C virus core protein. J. Virol. 79 (2005) 1271-1281
16. Kasprzak A., Seidel J., Biczysko W., Wysocki J., Spachacz R., and Zabel M. Intracellular localization of NS3 and C proteins in chronic hepatitis C. Liver Int. 25 (2005) 896-903
17. Griffin S., Clarke D., McCormick C., Rowlands D., and Harris M. Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes. J. Virol. 79 (2005) 15525-15536
18. Rouillé Y., Helle F., Delgrange D., Roingeard P., Voisset C., Blanchard E., Belouzard S., McKeating J., Patel A.H., Maertens G., Wakita T., Wychowski C., and Dubuisson J. Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J. Virol. 80 (2006) 2832-2841
19. Nomura-Takigawa Y., Nagano-Fujii M., Deng L., Kitazawa S., Ishido S., Sada K., and Hotta H. Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J. Gen. Virol. 87 (2006) 1935-1945
20. Rizzuto R., and Pozzan T. Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol. Rev. 86 (2006) 369-408
21. Szabadkai G., and Rizzuto R. Chaperones as parts of organelle networks. Adv. Exp. Med. Biol. 594 (2007) 64-77
22. Deryabina Y.I., Isakova E.P., and Zvyagilskaya R.A. Mitochondrial calcium transport systems: properties, regulation, and taxonomic features. Biochemistry (Moscow) 26 (2004) 190-195
23. Okuda M., Li K., Beard M.R., Showalter L.A., Scholle F., Lemon S.M., and Weinman S.A. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 (2002) 366-375
24. Korenaga M., Wang T., Li Y., Showalter L.A., Chan T., Sun J., and Weinman SA. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem. 280 (2005) 37481-37488
25. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Miyazawa T., Ishibashi K., Horie T., Imai K., Todoroki T., Kimura S., and Koike K. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 61 (2001) 4365-4370
26. Machida K., Cheng K.T., Lai C.K., Jeng K.S., Sung V.M., and Lai M.M. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J. Virol. 80 (2006) 7199-7207
27. Li Y., Boehning D.F., Qian T., Popov V.L., and Weinman S.A. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J. 21 (2007) 2474-2485
28. Moradpour D., Kary P., Rice C.M., and Blum H.E. Continuous human cell lines inducibly expressing hepatitis C virus structural and non-structural proteins. Hepatology 28 (2005) 192-201
29. Krause T., Gerbershagen M.U., Fiege M., Weisshorn R., and Wappler F. Dantrolene-a review of its pharmacology, therapeutic use and new developments. Anaesthesia 59 (2004) 364-373
30. Lin J.H., Walter P., and Yen T.S. Endoplasmic reticulum stress in disease pathogenesis. Annu. Rev. Pathol. 3 (2008) 399-425
31. Waris G., Tardif K.D., and Siddiqui A. Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem. Pharmacol. 64 (2002) 1425-1430
32. Tardif K.D., Mori K., Kaufman R.J., and Siddiqui A. A Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. J. Biol. Chem. 279 (2004) 17158-17164
33. Benali-Furet N.L., Chami M., Houel L., De Giorgi F., Vernejoul F., Lagorce D., Buscail L., Bartenschlager R., Ichas F., Rizzuto R., and Paterlini-Bréchot P. Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene 24 (2005) 4921-4933
34. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Kräusslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
35. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L., and Bartenschlager R. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7408-7413
36. Schaller T., Appel N., Koutsoudakis G., Kallis S., Lohmann V., Pietschmann T., and Bartenschlager R. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J. Virol. 81 (2007) 4591-4603
37. Lee S.K., Park S.O., Joe C.O., and Kim Y.S. Interaction of HCV core protein with 14-3-3epsilon protein releases Bax to activate apoptosis. Biochem. Biophys. Res. Commun. 352 (2007) 756-762
38. Chiou H.L., Hsieh Y.S., Hsieh M.R., and Chen T.Y. HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway. Biochem. Biophys. Res. Commun. 345 (2006) 453-458
39. Chou A.H., Tsai H.F., Wu Y.Y., Hu C.Y., Hwang L.H., Hsu P.I., and Hsu P.N. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 174 (2005) 2160-2216
40. Selimović D., and Hassan M. Inhibition of hepatitis C virus (HCV) core protein-induced cell growth by non-structural protein 4A (NS4A) is mediated by mitochondrial dysregulation. Bosn. J. Basic Med. Sci. 8 (2008) 4-11
41. Wang J., Tong W., Zhang X., Chen L., Yi Z., Pan T., Hu Y., Xiang L., and Yuan Z. Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells. FEBS Lett. 580 (2006) 4392-4400
42. Hara Y., Hino K., Okuda M., Furutani T., Hidaka I., Yamaguchi Y., Korenaga M., Li K., Weinman S.A., Lemon S.M., and Okita K. Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species. J. Gastroenterol. 41 (2006) 257-268
43. Lee S.H., Kim Y.K., Kim C.S., Seol S.K., Kim J., Cho S., Song Y.L., Bartenschlager R., and Jang S.K. E2 of hepatitis C virus inhibits apoptosis. J. Immunol. 175 (2005) 8226-8235
44. Meyer K., Basu A., Saito K., Ray R.B., and Ray R. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death. Virology 336 (2005) 198-207
45. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., Gassmann M., Gearhart J.D., Lawler A.M., Yu A.Y., and Semenza G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12 (1998) 149-162
46. Maxwell P.H. Hypoxia-inducible factor as a physiological regulator. Exp. Physiol. 90 (2005) 791-797
47. Kaelin W.G. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74 (2005) 115-128
48. Déry M.A., Michaud M.D., and Richard D.E. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 37 (2005) 535-540
49. Nasimuzzaman M., Waris G., Mikolon D., Stupack D.G., and Siddiqui A. Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J. Virol. 81 (2007) 10249-10257
50. Kenneth N.S., and Rocha S. Regulation of gene expression by hypoxia. Biochem. J. 414 (2008) 19-29
51. Galanis A., Pappa A., Giannakakis A., Lanitis E., Dangaj D., and Sandaltzopoulos R. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 266 (2008) 12-20
52. Nicholls D.G. Mitochondria and calcium signalling. Cell Calcium 38 (2005) 311-317
53. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., and Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287 (2004) 817-833
54. Rimessi A., Giorgi C., Pinton P., and Rizzuto R. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochim. Biophys. Acta 1777 (2008) 808-816
55. Ott M., Zhivotovsky B., and Orrenius S. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ. 14 (2007) 1243-1247
56. Ghafourifar P., and Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 26 (2005) 190-195
57. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552 (2003) 335-344
58. Jekabsone A., Ivanoviene L., Brown G.C., and Borutaite V. Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release. J. Mol. Cell Cardiol. 35 (2003) 803-809
59. Borutaite V., and Brown G.C. S-nitrosothiol inhibition of mitochondrial complex I causes a reversible increase in mitochondrial hydrogen peroxide production. Biochim. Biophys. Acta 1757 (2006) 562-566
60. Rydström J. Mitochondrial NADPH, transhydrogenase and disease. Biochim. Biophys. Acta 1757 (2006) 721-726
61. Beer S.M., Taylor E.R., Brown S.E., Dahm C.C., Costa N.J., Runswick M.J., and Murphy M.P. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J. Biol. Chem. 279 (2004) 47939-47951
62. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell Physiol. 192 (2002) 1-15
63. Boonstra J., and Post J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337 (2004) 1-13
64. Storz P. Reactive oxygen species in tumor progression. Front Biosci. 10 (2005) 1881-1896
65. Negro F. Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J. Gastroenterol. 12 (2006) 6756-6765
66. Zammit V.A. Carnitine palmitoyltransferase 1: central to cell function. IUBMB Life 60 (2008) 347-354
67. Bernardi P., Broekemeier K.M., and Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr. 26 (1994) 509-517
68. Hirsch T., Marzo I., and Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci. Rep. 17 (1997) 67-76
69. Tanaka N., Moriya K., Kiyosawa K., Koike K., Gonzalez F.J., and Aoyama T. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J. Clin. Invest. 118 (2008) 683-694
70. Kroemer G., Galluzzi L., and Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87 (2007) 99-163
71. Degterev A., and Yuan J. Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol. 9 (2008) 378-390